The 7th annual World Conference on Targeting Phage Therapy, focusing on the latest phage research, challenges, and future directions, is set to convene in Malta. This event will gather leading experts, researchers, and healthcare professionals to discuss advancements in phage therapy applications.
Credit: Targeting Phage Therapy 2024
The 7th annual World Conference on Targeting Phage Therapy, focusing on the latest phage research, challenges, and future directions, is set to convene in Malta. This event will gather leading experts, researchers, and healthcare professionals to discuss advancements in phage therapy applications.
Date: June 20-21, 2024
Venue: Corinthia Palace, Malta
Agenda Highlights:
Day 1 – June 20, 2024
- Keynote: Exploration of phage, phageome, and phage therapy.
- Session 1: Analysis of phages and hosts including recent developments.
- Session 2: Examination of microbiome & phageome interactions, and their medical implications.
- Round Table: Discussion on establishing a task force for phages and microbiome research.
Day 2 – June 21, 2024
- Session 3: Trends in phage therapy, including overcoming resistance and clinical study design.
- Session 4: Presentations on academic and industrial innovations.
- Session 5: Ethical and regulatory considerations in phage therapy.
Statement from the Scientific Board
Marvin Edeas, the President of the Scientific Board, shared what we’re aiming for with this Phage therapy 2024 conference: “We’re really looking to take phage therapy to the next level, making it useful for a wider range of health issues, beyond just infections. We see phages as a powerful tool for managing the body’s microbiota, which could really revolutionize how we care for patients”.
Scientific Board 2024
Barbara Brenner, Kanzlei BRENNER, Germany
Domenico Frezza, University of Roma Tor Vergata, Italy
Martha Clokie, Editor in Chief of PHAGE Journal, University of Leicester, United Kingdom
Daniel De Vos, Queen Astrid Military Hospital, Belgium
Mariagrazia Di Luca, University of Pisa, Italy
Marvin Edeas, INSERM – Institut Cochin, Université de Paris, France
Ekaterina Chernevskaya, Federal research and clinical center of intensive care medicine and rehabilitology, Russia
Cara Fiore, Food and Drug Administration (FDA), USA
Anders Nilsson, Stockholm University, Sweden
Jean-Paul Pirnay, Queen Astrid Military Hospital, Belgium
Anna Pistocchi, Università degli Studi di Milano, Italy
Brieuc Van Nieuwenhuyse, UCLouvain, Belgium
William Summers, Retired Professor at Yale University, USA
For more information and updates, visit the conference website.
